BASTIANELLI, Sabrina
 Distribuzione geografica
Continente #
NA - Nord America 269
EU - Europa 173
AS - Asia 116
SA - Sud America 1
Totale 559
Nazione #
US - Stati Uniti d'America 268
IE - Irlanda 66
IT - Italia 60
SG - Singapore 52
HK - Hong Kong 40
KR - Corea 13
CN - Cina 10
AT - Austria 7
DE - Germania 7
FI - Finlandia 7
FR - Francia 7
GB - Regno Unito 6
CZ - Repubblica Ceca 3
BE - Belgio 2
RU - Federazione Russa 2
SE - Svezia 2
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
LV - Lettonia 1
NL - Olanda 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 559
Città #
Dublin 66
Chandler 62
Singapore 43
Hong Kong 40
Boardman 24
Perugia 21
Santa Clara 17
Redmond 15
San Mateo 13
Seoul 13
Ann Arbor 10
Altamura 8
Bastia umbra 8
Medford 7
Princeton 7
Helsinki 6
Lawrence 6
Wilmington 6
Florence 5
Vienna 5
Andover 4
Los Angeles 4
New York 4
Paris 4
Ashburn 2
Beijing 2
Brussels 2
Dallas 2
Falkenstein 2
Milan 2
Munich 2
Padova 2
Seattle 2
Sinalunga 2
Tappahannock 2
West Jordan 2
Aachen 1
Anguillara Sabazia 1
Bari 1
Bogotá 1
Brno 1
Cambridge 1
Clifton 1
Den Haag 1
Edinburgh 1
Houston 1
Kiev 1
Lappeenranta 1
Lausanne 1
Nagold 1
Nanning 1
Norwalk 1
Olomouc 1
Prague 1
Riga 1
Rome 1
San José 1
Stockholm 1
Woodbridge 1
Totale 445
Nome #
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 67
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 65
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 63
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 53
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 47
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 45
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 41
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 30
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 29
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 27
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 24
Nelfinavir: An Old Ally in the COVID-19 Fight? 22
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 20
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 16
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 16
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 15
Kaposi Sarcoma in People Living with HIV: Is it Water under the Bridge? 11
Totale 591
Categoria #
all - tutte 4.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 1 0 0 1 1 0
2020/202143 1 0 0 4 5 1 0 1 0 14 1 16
2021/202274 7 15 1 2 2 2 0 14 0 3 21 7
2022/2023216 7 26 3 37 17 16 1 10 89 0 9 1
2023/2024120 5 14 7 0 1 2 42 1 12 9 13 14
2024/2025126 15 26 4 28 25 23 5 0 0 0 0 0
Totale 591